Pantelyushin, S.; Ranninger, E.; Guerrera, D.; Hutter, G.; Maake, C.; Markkanen, E.; Bettschart-Wolfensberger, R.; Rohrer Bley, C.; Läubli, H.; vom Berg, J.
Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs. Cancers 2021, 13, 785.
https://doi.org/10.3390/cancers13040785
AMA Style
Pantelyushin S, Ranninger E, Guerrera D, Hutter G, Maake C, Markkanen E, Bettschart-Wolfensberger R, Rohrer Bley C, Läubli H, vom Berg J.
Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs. Cancers. 2021; 13(4):785.
https://doi.org/10.3390/cancers13040785
Chicago/Turabian Style
Pantelyushin, Stanislav, Elisabeth Ranninger, Diego Guerrera, Gregor Hutter, Caroline Maake, Enni Markkanen, Regula Bettschart-Wolfensberger, Carla Rohrer Bley, Heinz Läubli, and Johannes vom Berg.
2021. "Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs" Cancers 13, no. 4: 785.
https://doi.org/10.3390/cancers13040785
APA Style
Pantelyushin, S., Ranninger, E., Guerrera, D., Hutter, G., Maake, C., Markkanen, E., Bettschart-Wolfensberger, R., Rohrer Bley, C., Läubli, H., & vom Berg, J.
(2021). Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs. Cancers, 13(4), 785.
https://doi.org/10.3390/cancers13040785